Stryker Gets Second FDA Warning Letter In A Year

FDA sent Stryker a warning letter, posted online Jan. 15, highlighting violations of quality system and "corrections and removals" regulations in the manufacture of hip, knee and shoulder implants

More from Archive

More from Medtech Insight